Pierre Peeters

1.3k total citations
37 papers, 1.0k citations indexed

About

Pierre Peeters is a scholar working on Molecular Biology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Pierre Peeters has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Psychiatry and Mental health and 7 papers in Pharmacology. Recurrent topics in Pierre Peeters's work include Anesthesia and Sedative Agents (7 papers), Epilepsy research and treatment (6 papers) and Lipid Membrane Structure and Behavior (5 papers). Pierre Peeters is often cited by papers focused on Anesthesia and Sedative Agents (7 papers), Epilepsy research and treatment (6 papers) and Lipid Membrane Structure and Behavior (5 papers). Pierre Peeters collaborates with scholars based in Netherlands, United States and Switzerland. Pierre Peeters's co-authors include J. H. G. Jonkman, Sjoerd P. van Marle, Daan J.A. Crommelin, Jean Smeets, Rita Schmitt, Cornelia Weber, Herbert Birnboeck, Gérard Hopfgartner, Pieter‐Jan de Kam and W. Eling and has published in prestigious journals such as Advanced Drug Delivery Reviews, Biochimica et Biophysica Acta (BBA) - Biomembranes and Neuropsychopharmacology.

In The Last Decade

Pierre Peeters

36 papers receiving 994 citations

Peers

Countries citing papers authored by Pierre Peeters

Since Specialization

Citations

This map shows the geographic impact of Pierre Peeters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Peeters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Peeters more than expected).

Fields of papers citing papers by Pierre Peeters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Peeters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Peeters. The network helps show where Pierre Peeters may publish in the future.

Co-authorship network of co-authors of Pierre Peeters

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Peeters. A scholar is included among the top collaborators of Pierre Peeters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Peeters. Pierre Peeters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of food on the high clearance drug asenapine after sublingual administration to healthy male volunteers 2014 ·European Journal of Clinical Pharmacology ·Peter Dogterom, Rik de Greef, Pierre Peeters	5
2	Effect of Sugammadex on QT/QTc Interval Prolongation when Combined with QTc-Prolonging Sevoflurane or Propofol Anaesthesia 2013 ·Clinical Drug Investigation ·Pieter‐Jan de Kam, Peter Grobara, (unknown), Guy Cammu, Steven Ramael, (unknown), Michiel W. van den Heuvel, Rob J. W. Berg, Pierre Peeters	17
3	Pharmacokinetic profile of nomegestrol acetate and 17β-estradiol after multiple and single dosing in healthy women 2012 ·Contraception ·(unknown), Peter Schnabel, Teun M. Post, Pierre Peeters	32
4	Asenapine Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers 2012 ·Clinical Pharmacology in Drug Development ·Peter Dogterom, C. J. Timmer, Rik de Greef, Edwin Spaans, (unknown), André van Vliet, Pierre Peeters	7
5	Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype 2011 ·Psychopharmacology ·Johannes G. Ramaekers, Silke Conen, Pieter Jan de Kam, Sabine Braat, Pierre Peeters, Eef L. Theunissen, Neely Ivgy-May	27
6	Asenapine Pharmacokinetics in Hepatic and Renal Impairment 2011 ·Clinical Pharmacokinetics ·Pierre Peeters, Howard N. Bockbrader, Edwin Spaans, Peter Dogterom, Kenneth C. Lasseter, Thomas Marbury, (unknown), Rik de Greef	21
7	Flucloxacillin and Diclofenac do not Cause Recurrence of Neuromuscular Blockade after Reversal with Sugammadex 2011 ·Clinical Drug Investigation ·Pieter‐Jan de Kam, Martijn P. van den Heuvel, Peter Grobara, Alex Zwiers, (unknown), (unknown), Steven Ramael, Pierre Peeters	9
8	Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence 2011 ·Neuropsychopharmacology ·Deepak Cyril D’Souza, Nagendra M. Singh, (unknown), Michelle Carbuto, Brian Pittman, (unknown), Magnus Sjögren, Pierre Peeters, Mohini Ranganathan, J. Schipper	45
9	Valproate Reduces the Glucuronidation of Asenapine Without Affecting Asenapine Plasma Concentrations 2011 ·The Journal of Clinical Pharmacology ·(unknown), Rik de Greef, Peter Dogterom, Pierre Peeters	14
10	Obliged permanent pastures : main future of ruminant production in Belgium 2011 ·Open Repository and Bibliography (University of Liège) ·Didier Stilmant, Pierre M Stassart, Pierre Peeters, (unknown), (unknown), Marc Mormont	1
11	Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects 2010 ·Clinical Drug Investigation ·Pierre Peeters, Michiel W. van den Heuvel, (unknown), Paul Passier, Jean Smeets, Thijs van Iersel, Alex Zwiers	53
12	Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects 2010 ·Biopharmaceutics & Drug Disposition ·(unknown), Rik de Greef, Pierre Peeters	21
13	Effects of Sugammadex Doses up to 32 mg/kg Alone or in Combination with Rocuronium or Vecuronium on QTc Prolongation 2010 ·Clinical Drug Investigation ·Pieter‐Jan de Kam, (unknown), Marita Prohn, T. Thomsen, Pierre Peeters	38
14	Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects 1996 ·Clinical Pharmacology & Therapeutics ·Cornelia Weber, Rita Schmitt, Herbert Birnboeck, Gérard Hopfgartner, Sjoerd P. van Marle, Pierre Peeters, J. H. G. Jonkman, (unknown)	178
15	Switch in Treatment From Tricyclic Antidepressants to Moclobemide 1995 ·Journal of Clinical Psychopharmacology ·Jasper Dingemanse, J Kneer, (unknown), Henk Groen, Pierre Peeters, J. H. G. Jonkman	10
16	Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ 1989 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Pierre Peeters, (unknown), W. Eling, (unknown)	18
17	Chloroquine Blood Levels After Administration of the Liposome-Encapsulated Drug in Relation to Therapy of Murine Malaria 1989 ·Pharmaceutical Research ·Pierre Peeters, (unknown), W. Eling, Daan J.A. Crommelin	15
18	Immunospecific targeting of liposomes to erythrocytes 1988 ·Biochemical Pharmacology ·Pierre Peeters, (unknown), W. Eling, Daan J.A. Crommelin	23
19	Immunospecific targeting of immunoliposomes, F(ab′)2 and IgG to red blood cells in vivo 1988 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Pierre Peeters, Christien Oussoren, W. Eling, Daan J.A. Crommelin	22
20	Association of sodium salicylate to isolated leucocytes 1984 ·Biochemical Pharmacology ·M. Raghoebar, (unknown), Pierre Peeters, (unknown), C. A. M. van Ginneken, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact